AgingResearch.NewsJoin free

Respite care

Intervention

1 paper2 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 1 lab in 1 country
  • Human trial1

Outcomes

2

Cognitive function

upin humans1

1 study

  1. Respite care improves cognitive function in humans (RCI = 1.2).

    “Further, RBANS (RCI = 1.2), immediate memory index (RCI = 4.58), language index (RCI = 3.16), attention index (RCI = 1.58), and delayed memory index (RCI = 2.33) scores increased.”

    Human trial12 weeksn = 8

    IMPACT OF RESPITE SERVICES ON DEMENTIA CAREGIVERS’ NEUROCOGNITIVE AND PREDEATH GRIEF OUTCOMES: A PILOT STUDY

    GSA 2024 abstract31 Dec 2024

Pre-death grief

downin humans1

1 study

  1. Respite care decreases pre-death grief in humans (RCI = -0.88).

    “Average PG-12 scores decreased (RCI = -0.88) at intervention, indicating a decrease in PDG.”

    Human trial12 weeksn = 8

    IMPACT OF RESPITE SERVICES ON DEMENTIA CAREGIVERS’ NEUROCOGNITIVE AND PREDEATH GRIEF OUTCOMES: A PILOT STUDY

    GSA 2024 abstract31 Dec 2024

Latest

Related